20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Oculis Holding AG Ordinary shares (OCS) operates in the BIOTECHNOLOGY industry and is headquartered in Zug, Switzerland with about 60 employees. Its market capitalization is roughly $470 million. In the fiscal year ended 2025-12-31, OCS reported CHF 0M in revenue and (CHF 95M) in net income.
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.
Interactive charts & full statements → Open the OCS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | CHF 0M | CHF 0M | CHF 1M | CHF 1M | CHF 1M | CHF 1M | CHF 1M |
| Gross Profit | — | — | (CHF 51M) | (CHF 28M) | (CHF 21M) | (CHF 9M) | (CHF 8M) |
| Gross Margin % | — | — | -7492.3% | -3212.2% | -2336.8% | -896.7% | -840.3% |
| Operating Income (EBIT) | (CHF 87M) | (CHF 79M) | (CHF 73M) | (CHF 81M) | (CHF 32M) | (CHF 13M) | (CHF 12M) |
| Operating Margin % | -35874.2% | — | -10671.1% | -9140.9% | -3550.0% | -1378.3% | -1242.3% |
| Net Income | (CHF 80M) | (CHF 95M) | (CHF 86M) | (CHF 89M) | (CHF 39M) | (CHF 19M) | (CHF 15M) |
| Net Margin % | -32780.2% | — | -12503.9% | -10056.9% | -4243.2% | -1932.5% | -1497.8% |
| EBITDA | (CHF 79M) | (CHF 93M) | (CHF 86M) | (CHF 87M) | (CHF 32M) | (CHF 13M) | (CHF 12M) |
| Earnings Per Share (EPS) | CHF -1.40 | CHF -1.81 | CHF -2.12 | CHF -2.97 | CHF -1.18 | CHF -0.57 | CHF -0.45 |
| Shares Outstanding (M) | 61M | 52M | 40M | 30M | 33M | 33M | 33M |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 0M |
| Gross Profit | — | CHF 0M | — | CHF 0M | (CHF 15M) | — | — | — |
| Gross Margin % | — | — | — | 100.0% | -5612.3% | — | — | — |
| Operating Income (EBIT) | (CHF 24M) | (CHF 22M) | (CHF 21M) | (CHF 20M) | (CHF 21M) | (CHF 20M) | (CHF 17M) | (CHF 18M) |
| Operating Margin % | — | — | — | -8352.3% | -7957.1% | — | — | — |
| Net Income | (CHF 10M) | (CHF 29M) | (CHF 23M) | (CHF 17M) | (CHF 25M) | (CHF 33M) | (CHF 29M) | (CHF 20M) |
| Net Margin % | — | — | — | -6936.2% | -9722.2% | — | — | — |
| EBITDA | (CHF 9M) | (CHF 29M) | (CHF 23M) | (CHF 16M) | (CHF 25M) | (CHF 33M) | (CHF 29M) | (CHF 20M) |
| Earnings Per Share (EPS) | CHF -0.16 | CHF -0.50 | CHF -0.42 | CHF -0.32 | CHF -0.49 | CHF -0.69 | CHF -0.69 | CHF -0.48 |
| Shares Outstanding (M) | 61M | 59M | 56M | 53M | 52M | 48M | 42M | 42M |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | (CHF 66M) | (CHF 62M) | (CHF 47M) | (CHF 54M) | (CHF 25M) | (CHF 14M) | (CHF 12M) |
| Capital Expenditures (CapEx) | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 4M | CHF 0M | CHF 0M |
| Free Cash Flow (FCF) | (CHF 66M) | (CHF 63M) | (CHF 48M) | (CHF 54M) | (CHF 29M) | (CHF 14M) | (CHF 12M) |
| FCF Margin % | -27182.0% | — | -6957.6% | -6103.4% | -3138.4% | -1443.0% | -1213.3% |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | (CHF 20M) | (CHF 16M) | (CHF 17M) | (CHF 13M) | (CHF 17M) | (CHF 19M) | (CHF 10M) | (CHF 10M) |
| Capital Expenditures (CapEx) | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 0M | CHF 1M | CHF 0M | CHF 0M |
| Free Cash Flow (FCF) | (CHF 20M) | (CHF 16M) | (CHF 17M) | (CHF 14M) | (CHF 17M) | (CHF 20M) | (CHF 10M) | (CHF 11M) |
| FCF Margin % | — | — | — | -5572.8% | -6654.4% | — | — | — |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Assets | CHF 250M | CHF 236M | CHF 120M | CHF 114M | CHF 37M | CHF 58M | CHF 16M |
| Cash & Cash Equivalents | CHF 0M | CHF 81M | CHF 28M | CHF 38M | CHF 20M | CHF 46M | CHF 5M |
| Total Liabilities | CHF 31M | CHF 40M | CHF 47M | CHF 21M | CHF 135M | CHF 119M | CHF 60M |
| Total Debt (Short + Long-Term) | CHF 1M | CHF 1M | CHF 0M | CHF 0M | CHF 123M | CHF 114M | CHF 54M |
| Total Shareholders' Equity | CHF 219M | CHF 196M | CHF 73M | CHF 94M | (CHF 98M) | (CHF 61M) | (CHF 44M) |
CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OCS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms